The carrier screening market size has grown rapidly in recent years. It will grow from $3.16 billion in 2025 to $3.68 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to increasing awareness of genetic disorders, expansion of prenatal and preconception testing, advancements in dna sequencing technologies, growing use of laboratory-based diagnostics, improved access to genetic counseling services.
The carrier screening market size is expected to see rapid growth in the next few years. It will grow to $6.57 billion in 2030 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising investments in genomic research, expansion of population-wide screening initiatives, growing adoption of ai-based genomic analytics, increasing focus on preventive healthcare strategies. Major trends in the forecast period include increasing adoption of expanded carrier screening panels, rising use of next-generation sequencing technologies, growing integration of ai in genetic data interpretation, expansion of preventive genetic testing programs, enhanced focus on reproductive health screening.
The growing geriatric population is expected to drive the expansion of the carrier screening market in the coming years. The geriatric population refers to the demographic group consisting of elderly or older individuals. Older adults, particularly those considering having children later in life, may choose carrier screening as part of preconception or prenatal care to assess the genetic risks associated with advanced parental age. For example, in October 2025, according to the Office for National Statistics, the UK’s largest independent producer of official statistics, there were 625,000 people aged 90 or above in the UK in 2024, up from 612,000 in mid-2023, reflecting a 2.2% increase. Hence, the rising geriatric population is contributing to the growth of the carrier screening market.
Key players in the carrier screening market are concentrating on product innovations, such as carrier screening panels, to maintain their market presence. A carrier screening panel consists of a set of genetic tests designed to detect individuals carrying gene mutations for specific genetic conditions, even if they do not show symptoms of the condition. For instance, in February 2023, Fulgent Genetics, Inc., a US-based genetic testing and diagnostics company, launched its latest product, the Beacon787 expanded carrier screening panel. This panel includes 787 genes associated with autosomal recessive and X-linked conditions, covering all American College of Medical Genetics and Genomics (ACMG) Tier 3 genes. The inclusion of these genes follows ACMG’s updated practice guidelines, recommending comprehensive screening for all pregnant individuals and those planning pregnancies. Fulgent’s Beacon787 aims to deliver a pan-ethnic and equitable screening approach, highlighting the company’s commitment to advancing genetic testing for a wider array of conditions and supporting informed family planning decisions.
In January 2024, Natera, a U.S.-based genetic testing and diagnostics company, acquired reproductive health assets from Invitae Corporation for an undisclosed amount. Through this acquisition, Natera aims to broaden its reproductive health testing portfolio, reinforce its market presence, and improve service offerings for fertility and prenatal care. Invitae Corporation is a U.S.-based medical genetics company that provides carrier screening.
Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Illumina Inc., Laboratory Corporation of America Holdings, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., Associated Regional and University Pathologists Inc., GeneDx LLC, GenPath Consultants and Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.
North America was the largest region in the carrier screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the carrier screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the carrier screening market by increasing costs of imported sequencing instruments, reagents, laboratory consumables, and bioinformatics hardware used in genetic testing workflows. Reference laboratories and hospitals in North America and Europe are most affected due to reliance on imported genomic technologies, while Asia-Pacific faces higher costs for equipment procurement. These tariffs are raising test prices and limiting laboratory expansion. At the same time, they are encouraging domestic manufacturing of diagnostic reagents, regional laboratory infrastructure development, and local innovation in genetic testing solutions.
The carrier screening market research report is one of a series of new reports that provides carrier screening market statistics, including carrier screening industry global market size, regional shares, competitors with a carrier screening market share, detailed carrier screening market segments, market trends and opportunities, and any further data you may need to thrive in the carrier screening industry. This carrier screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Carrier screening is a type of genetic test that can detect whether a person carries a gene associated with certain genetic disorders. It is used to identify individuals who have one copy of a gene mutation that can lead to a hereditary disease if two copies are present.
The primary forms of carrier screening are expanded carrier screening and targeted disease carrier screening. Expanded carrier screening enables testing for multiple autosomal and X-linked recessive disorders through advanced genetic testing technologies and allows testing of individuals regardless of their ancestry or geographic origin. The offerings include both products and services. The medical conditions covered include pulmonary conditions, hematological conditions, neurological conditions, and other disorders. The technologies utilized comprise DNA sequencing, polymerase chain reaction, microarrays, and additional methods. The end users include hospitals, reference laboratories, physician offices and clinics, and other groups.
The carrier screening market includes revenues earned by entities by providing customized panel testing and predesigned panel testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The carrier screening market size is expected to see rapid growth in the next few years. It will grow to $6.57 billion in 2030 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising investments in genomic research, expansion of population-wide screening initiatives, growing adoption of ai-based genomic analytics, increasing focus on preventive healthcare strategies. Major trends in the forecast period include increasing adoption of expanded carrier screening panels, rising use of next-generation sequencing technologies, growing integration of ai in genetic data interpretation, expansion of preventive genetic testing programs, enhanced focus on reproductive health screening.
The growing geriatric population is expected to drive the expansion of the carrier screening market in the coming years. The geriatric population refers to the demographic group consisting of elderly or older individuals. Older adults, particularly those considering having children later in life, may choose carrier screening as part of preconception or prenatal care to assess the genetic risks associated with advanced parental age. For example, in October 2025, according to the Office for National Statistics, the UK’s largest independent producer of official statistics, there were 625,000 people aged 90 or above in the UK in 2024, up from 612,000 in mid-2023, reflecting a 2.2% increase. Hence, the rising geriatric population is contributing to the growth of the carrier screening market.
Key players in the carrier screening market are concentrating on product innovations, such as carrier screening panels, to maintain their market presence. A carrier screening panel consists of a set of genetic tests designed to detect individuals carrying gene mutations for specific genetic conditions, even if they do not show symptoms of the condition. For instance, in February 2023, Fulgent Genetics, Inc., a US-based genetic testing and diagnostics company, launched its latest product, the Beacon787 expanded carrier screening panel. This panel includes 787 genes associated with autosomal recessive and X-linked conditions, covering all American College of Medical Genetics and Genomics (ACMG) Tier 3 genes. The inclusion of these genes follows ACMG’s updated practice guidelines, recommending comprehensive screening for all pregnant individuals and those planning pregnancies. Fulgent’s Beacon787 aims to deliver a pan-ethnic and equitable screening approach, highlighting the company’s commitment to advancing genetic testing for a wider array of conditions and supporting informed family planning decisions.
In January 2024, Natera, a U.S.-based genetic testing and diagnostics company, acquired reproductive health assets from Invitae Corporation for an undisclosed amount. Through this acquisition, Natera aims to broaden its reproductive health testing portfolio, reinforce its market presence, and improve service offerings for fertility and prenatal care. Invitae Corporation is a U.S.-based medical genetics company that provides carrier screening.
Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Illumina Inc., Laboratory Corporation of America Holdings, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., Associated Regional and University Pathologists Inc., GeneDx LLC, GenPath Consultants and Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.
North America was the largest region in the carrier screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the carrier screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the carrier screening market by increasing costs of imported sequencing instruments, reagents, laboratory consumables, and bioinformatics hardware used in genetic testing workflows. Reference laboratories and hospitals in North America and Europe are most affected due to reliance on imported genomic technologies, while Asia-Pacific faces higher costs for equipment procurement. These tariffs are raising test prices and limiting laboratory expansion. At the same time, they are encouraging domestic manufacturing of diagnostic reagents, regional laboratory infrastructure development, and local innovation in genetic testing solutions.
The carrier screening market research report is one of a series of new reports that provides carrier screening market statistics, including carrier screening industry global market size, regional shares, competitors with a carrier screening market share, detailed carrier screening market segments, market trends and opportunities, and any further data you may need to thrive in the carrier screening industry. This carrier screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Carrier screening is a type of genetic test that can detect whether a person carries a gene associated with certain genetic disorders. It is used to identify individuals who have one copy of a gene mutation that can lead to a hereditary disease if two copies are present.
The primary forms of carrier screening are expanded carrier screening and targeted disease carrier screening. Expanded carrier screening enables testing for multiple autosomal and X-linked recessive disorders through advanced genetic testing technologies and allows testing of individuals regardless of their ancestry or geographic origin. The offerings include both products and services. The medical conditions covered include pulmonary conditions, hematological conditions, neurological conditions, and other disorders. The technologies utilized comprise DNA sequencing, polymerase chain reaction, microarrays, and additional methods. The end users include hospitals, reference laboratories, physician offices and clinics, and other groups.
The carrier screening market includes revenues earned by entities by providing customized panel testing and predesigned panel testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Carrier Screening Market Characteristics
3. Carrier Screening Market Supply Chain Analysis
4. Global Carrier Screening Market Trends and Strategies
5. Carrier Screening Market Analysis of End Use Industries
7. Global Carrier Screening Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Carrier Screening Total Addressable Market (TAM) Analysis for the Market
9. Carrier Screening Market Segmentation
10. Carrier Screening Market Regional and Country Analysis
11. Asia-Pacific Carrier Screening Market
12. China Carrier Screening Market
13. India Carrier Screening Market
14. Japan Carrier Screening Market
15. Australia Carrier Screening Market
16. Indonesia Carrier Screening Market
17. South Korea Carrier Screening Market
18. Taiwan Carrier Screening Market
19. South East Asia Carrier Screening Market
20. Western Europe Carrier Screening Market
21. UK Carrier Screening Market
22. Germany Carrier Screening Market
23. France Carrier Screening Market
24. Italy Carrier Screening Market
25. Spain Carrier Screening Market
26. Eastern Europe Carrier Screening Market
27. Russia Carrier Screening Market
28. North America Carrier Screening Market
29. USA Carrier Screening Market
30. Canada Carrier Screening Market
31. South America Carrier Screening Market
32. Brazil Carrier Screening Market
33. Middle East Carrier Screening Market
34. Africa Carrier Screening Market
36. Carrier Screening Market Competitive Landscape and Company Profiles
37. Carrier Screening Market Other Major and Innovative Companies
40. Carrier Screening Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Carrier Screening Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses carrier screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for carrier screening? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The carrier screening market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Expanded Carrier Screening; Targeted Disease Carrier Screening2) By Medical Condition: Pulmonary Conditions; Hematological Conditions; Neurological Conditions; Other Medical Conditions
3) By Technology: DNA Sequencing; Polymerase Chain Reaction; Microarrays; Other Technologies
4) By End User: Hospitals; Reference Laboratories; Physician Offices And Clinics; Other End Users
Subsegments:
1) By Expanded Carrier Screening: Next-Generation Sequencing (NGS) Panels; Comprehensive Carrier Screening Tests2) By Targeted Disease Carrier Screening: Single Gene Tests; Disease-Specific Panels; Ethnic Or Population-Specific Screening Tests
Companies Mentioned: Invitae Corporation; BGI Genomics Co. Ltd.; Centogene NV; Eurofins Scientific SE; Fulgent Genetics Inc.; Illumina Inc.; Laboratory Corporation of America Holdings; MedGenome Inc.; Myriad Genetics Inc.; Natera Inc.; OPKO Health Inc.; Otogenetics Corporation; Quest Diagnostics Inc.; Sema4 Holdings Corporation; Thermo Fisher Scientific Inc.; Associated Regional and University Pathologists Inc.; GeneDx LLC; GenPath Consultants and Technologies Private Limited; Good Start Genetics Inc.; NIPD Genetics Co. Pvt. Ltd.; Pathway Genomics Corp.; PerkinElmer Inc.; PreventionGenetics LLC; Progenity Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Carrier Screening market report include:- Invitae Corporation
- BGI Genomics Co. Ltd.
- Centogene NV
- Eurofins Scientific SE
- Fulgent Genetics Inc.
- Illumina Inc.
- Laboratory Corporation of America Holdings
- MedGenome Inc.
- Myriad Genetics Inc.
- Natera Inc.
- OPKO Health Inc.
- Otogenetics Corporation
- Quest Diagnostics Inc.
- Sema4 Holdings Corporation
- Thermo Fisher Scientific Inc.
- Associated Regional and University Pathologists Inc.
- GeneDx LLC
- GenPath Consultants and Technologies Private Limited
- Good Start Genetics Inc.
- NIPD Genetics Co. Pvt. Ltd.
- Pathway Genomics Corp.
- PerkinElmer Inc.
- PreventionGenetics LLC
- Progenity Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.68 Billion |
| Forecasted Market Value ( USD | $ 6.57 Billion |
| Compound Annual Growth Rate | 15.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
